Towards comprehensive clinical trials for new tuberculosis drug regimens: policy recommendations from a stakeholder analysis
Background Research and development (R&D) of new drugs and regimens against tuberculosis (TB) is evolving to meet new challenges and face limited investments in the sector. To effectively improve and fill existing gaps, researchers and trialists should engage a broad spectrum of stakeholders. Wi...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2024-04-01
|
| coleção: | BMJ Global Health |
| Acesso em linha: | https://gh.bmj.com/content/9/4/e014630.full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|